Oxolinic acid in urinary tract infection a multi-centre trial

Summary

A single-blind trial of oxolinic acid (750?mg. twice-daily for 14 days) and ampicillin (500?mg. 3-times daily for 14 days) in 60 cases with urinary tract symptoms showed superior results with oxolinic acid: 94 % of pathogens were sensitive to oxolinic acid and 69 % were sensitive to ampicillin. Symptomatic relief and bacterial eradication occurred earlier in the oxolinic acid group.